0001214659-24-010004.txt : 20240528 0001214659-24-010004.hdr.sgml : 20240528 20240528115751 ACCESSION NUMBER: 0001214659-24-010004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240523 FILED AS OF DATE: 20240528 DATE AS OF CHANGE: 20240528 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wasoff Evan L CENTRAL INDEX KEY: 0001719738 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55320 FILM NUMBER: 24988488 MAIL ADDRESS: STREET 1: 101 WINGER DRIVE CITY: NEDERLAND STATE: CO ZIP: 80466 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEXIEN BIOPHARMA, INC. CENTRAL INDEX KEY: 0001625288 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 262049376 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 4340 E KENTUCKY AVE STREET 2: SUITE 206 CITY: GLENDALE STATE: CO ZIP: 80246 BUSINESS PHONE: 3034957583 MAIL ADDRESS: STREET 1: 4340 E KENTUCKY AVE STREET 2: SUITE 206 CITY: GLENDALE STATE: CO ZIP: 80246 FORMER COMPANY: FORMER CONFORMED NAME: Intiva BioPharma Inc. DATE OF NAME CHANGE: 20171129 FORMER COMPANY: FORMER CONFORMED NAME: Kinder Holding Corp. DATE OF NAME CHANGE: 20141114 4 1 marketforms-66041.xml PRIMARY DOCUMENT X0508 4 2024-05-23 0001625288 NEXIEN BIOPHARMA, INC. NXEN 0001719738 Wasoff Evan L 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246 false true false false Chief Financial Officer 0 Common stock 2024-05-23 4 A false 2000000 A 6500000 D Options to purchase common stock (right to buy) 0.08 2020-08-19 2027-08-19 common stock 1500000 1500000 D Options to purchase common stock (right to buy) 0.54 2018-07-25 2025-07-25 common stock 420000 420000 D Options to purchase common stock (right to buy) 0.655 2018-10-26 2025-10-26 common stock 200000 200000 D Issued in lieu of compensation for services. Evan L. Wasoff 2024-05-28